Marked Choroidal Thinning Observed after Intravitreal Brolucizumab Injection
Introduction: Here, we report a case of severe intraocular inflammation (IOI) and prominent choroidal thinning following the initial intravitreal brolucizumab injection (IVBr). Case Presentation: The patient was a 75-year-old Japanese man with type 2 age-related macular degeneration of both eyes. Un...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2023-11-01
|
| Series: | Case Reports in Ophthalmology |
| Subjects: | |
| Online Access: | https://beta.karger.com/Article/FullText/534817 |